Mandate

Vinge advises the founders of Modular Finance in connection with a transaction with Sprints

Vinge advises the founders of Modular Finance in connection with a sale of approximately 40% of the shares in the company to Sprints.

Modular Finance is a SaaS company focusing on the financial markets in the Nordics and the United Kingdom. Through two business areas, Banking & Finance and Investor Relations, a range of niche products is offered with a focus on unique data sets and user-friendliness.

Sprints has a team founded and led by Swedes but headquartered in the UK, and is a focused investor in tech-enabled companies with prior experience as investors in Hemnet and existing investments in companies such as Teamtailor, Planhat, Vinted and Revolut.

The company’s founders Måns Flodberg, Rasmus Holm and Petter Hedborg will retain the majority of their shares and will remain fully involved over the coming years. Rite Ventures which has been a partner since 2014 will also keep the majority of their shares.

Vinge’s team consisted of partners Christina Kokko and Karl Klackenberg together with Viktor Lennartsson, Egil Svensson and Gustav Persson (M&A), Victor Ericsson and Morgan Ödman (Tax), and Daniel Wendelsson (Regulatory).

Related

Vinge advises Egetis Therapeutics in connection with ANI Pharmaceuticals’ public cash offer

On 5 November 2026, ANI Pharmaceuticals, Inc., a U.S. biopharmaceutical company listed on The Nasdaq Global Market, announced a recommended public cash offer to the shareholders of Egetis Therapeutics AB (publ) and to the holder of Egetis’ convertible loan and warrants to tender all shares, the convertible loan and the warrants in Egetis to ANI. The total value of the offer amounts to approximately SEK 5,304 million.
November 10, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 90 million before transaction costs, with an over-allotment issue of approximately SEK 72 million.
November 09, 2026

Vinge advises SenzaGen on its acquisition of Alcyomics

SenzaGen AB (publ) has acquired Alcyomics Ltd. The transaction is being financed through a combination of existing cash and a directed issue of convertible bonds.
November 09, 2026